Muñoz Martín, Andrés http://orcid.org/0000-0001-6977-8249
Trujillo-Santos, Antonio Javier
Martí, Edelmira http://orcid.org/0000-0002-5678-2916
Jara-Palomares, Luis
Macías Montero, Raquel
Gallardo, Enrique http://orcid.org/0000-0002-1375-3488
López-Núñez, Juan José http://orcid.org/0000-0002-1226-2353
Brozos-Vázquez, Elena
Robles-Marinas, Verónica
Pérez-Segura, Pedro
Ruíz-Artacho, Pedro
Funding for this research was provided by:
Universidad Complutense de Madrid
Article History
Received: 21 September 2023
Accepted: 21 December 2023
First Online: 13 February 2024
Declarations
:
: AJMM: Consultant or Advisory role of Pfizer-BMS, Sanofi, Celgene, Leo Pharma, Incyte, Astra-Zeneca, MSD, Lilly, Servier, Bayer, Roche, GSK; Research funding from Celgene, Sanofi, Leo Pharma, Rovi; Speakers’ bureau for Rovi, Bayer, Menarini, Stada, Daichii Sankyo; Patents, Royalties, Other Intellectual Property: Risk assessment model of venous thromboembolism in cancer patients. EM: personal fees from Daiichi-Sankyo, Bristol-Myers, Bayer, Pfizer, Boehringher Ingelheim, LeoPharma and Rovi outside the submitted work. LJP: personal fees from Bayer HealthCare Pharmaceuticals, Johnson & Johnson, Rovi, Pfizer, Bristol-Myers Squibb, MSD and Leo Pharma. EG: Consultant or Advisory Role for Sanofi, Janssen, Astellas, Bayer, Ipsen, Pfizer, Roche, Novartis, Eisai, EUSA Pharma, BMS, MSD, AstraZeneca, Merck, Rovi, Daiichi Sankyo, Techdow, Lilly, Advanced Accelerator Applications. Speaking: Astellas, Janssen, Sanofi, Bayer, Ipsen, Pfizer, Roche, BMS, Rovi, Daiichi Sankyo, Leo Pharma, Eisai, Boehringer Ingelheim, Merck, EUSA Pharma, Lilly, Advanced Accelerator Applications. Grant support: Astellas, Janssen, Sanofi, Bayer, Ipsen, Ferrer, Pfizer, Roche, GSK, BMS. Travel/acommodation expenses: Astellas, Janssen, Sanofi, BMS, Bayer, Ipsen, Roche, Novartis, Pierre Fabre, Pfizer, Eisai, AstraZeneca. VRM: advisor or consultant for Pfizer, Bayer; speaker for Pfizer, Bayer, Daiichi Sankyo, Rovi, GSK, Bristol-Myers Squibb. PRA: advisor or consultant for Leo Pharma, Pfizer and Viatris; speaker or member of a speakers’ bureau for Bristol-Myers Squibb, Daiichi Sankyo, Leo Pharma, ROVI and Viatris; grants for clinical research from ROVI. The other authors did not report any conflict of interest.
: This is an article about the management of patients in hospitals from experts' opinion. No research involving human participants.
: No informed consent need.